KPV
A tripeptide fragment of alpha-MSH studied in animal research; not FDA-approved.
What it is
KPV is a three-amino-acid fragment — the tail of alpha-MSH — studied in the lab for anti-inflammatory activity, notably in gut and skin models. It's one of the newer arrivals in gray-market peptide catalogs.
The research is cell and animal work, much of it on inflammatory-bowel models, some exploring oral delivery. Published controlled human trials don't exist, and no regulatory pathway has been started anywhere.
What researchers have actually studied it for
Inflammation in cell and animal models — particularly gut (colitis models) and skin; human trials have not been published.
How it works
Lysine-proline-valine — alpha-MSH's C-terminal tail, which carries the parent hormone's anti-inflammatory signaling without its pigmentation activity. Proposed actions include entering cells via peptide transporters (PepT1, enriched in inflamed gut) and damping NF-κB-driven inflammatory programs.
Where it came from
Alpha-MSH fragment mapping in the 1980s–90s identified KPV as the anti-inflammatory core; academic groups later made it a favorite tool in rodent colitis and dermatitis models, including nanoparticle oral-delivery work in the 2010s. Commercial gray-market interest is recent and runs well ahead of the science.
What the research record actually contains
- Rodent colitis studies: reduced inflammation with oral or systemic KPV.
- Skin and wound-model work in animals and cell culture.
- No published human trials of any kind.
What's known about risks
No human data. A benign-sounding tripeptide with zero human characterization deserves the same caution the pattern always deserves.
Where it stands legally
Never approved; research-chemical channel only.
Worth asking a licensed provider
- 1.If gut inflammation is my concern, have we done the actual work-up — and tried evaluated therapies?
- 2.Is there any human study of KPV you can point to? (There isn't — what does that imply?)
- 3.What's the plan for objectively tracking my inflammation either way?